Elos Medtech appoints Jan Wahlström as new President and CEO as of 1 July 2016
As previously announced, President Johannes Lind-Widestam has decided to step down effective 30 June 2016. Johannes Lind-Widestam will be succeeded by Jan Wahlström, who will take up his position on 1 July 2016. Jan joins Elos Medtech from his role as President of Larodan AB. Larodan develops, manufactures and markets high-quality lipids for chemical research in the international market. Previous positions held include President of Biolin Scientific and senior positions at several medical technology companies.Stig-Arne Blom, Chairman of the Board of Elos Medtech says: “We are extremely